FARZANA AJMAL

Allopathic & Osteopathic Physicians|Family Medicine|Geriatric Medicine GERMANTOWN, MD NPI 1497841563

General Payments — all program years on this page

$2,871.12

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 60
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $782.21 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $782.2115

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $243.324
Amgen Inc. $126.253
Gilead Sciences, Inc. $121.841
Exact Sciences Corporation $106.944
Lilly USA, LLC $93.851
TACTILE SYSTEMS TECHNOLOGY INC $74.431
Novo Nordisk AS $15.581

By program year

Program yearAmountRecords
2018 $250.437
2019 $380.806
2020 $122.353
2021 $70.734
2022 $369.347
2023 $895.2618
2024 $782.2115

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1082362071 Tactile Systems Technology Inc $74.43 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096983997 Novo Nordisk Inc $15.58 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104264157 AstraZeneca Pharmaceuticals LP $16.99 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105446941 AstraZeneca Pharmaceuticals LP $25.81 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105569401 AstraZeneca Pharmaceuticals LP $78.68 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105870823 AstraZeneca Pharmaceuticals LP $121.84 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111511547 Amgen Inc. $23.18 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111511549 Amgen Inc. $15.73 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111511551 Amgen Inc. $87.34 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114571982 Exact Sciences Corporation $29.25 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114571986 Exact Sciences Corporation $25.86 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114571990 Exact Sciences Corporation $26.73 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114571994 Exact Sciences Corporation $25.10 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133750164 Gilead Sciences, Inc. $121.84 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134972459 Lilly USA, LLC $93.85 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.